AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GLICLAZIDE BP
4 registrations across 4 African markets— 2 active
Markets with GLICLAZIDE BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| GLICOR MR TABLETS | 🇷🇼Rwanda | STALLION LABORATORIES PVT. LTD | active | Sept 2030 |
| Diabend tablets Tablet Uncoated | 🇿🇲Zambia | Bal Pharma Limited | active | Mar 2030 |
| MELANOV-80 80MG UNCOATED TABLETS UNCOATED TABLETS | 🇲🇼Malawi | — | expired | Mar 2024 |
| CIZIDE-M TABLET | 🇳🇬Nigeria | HAVANA PHARM & CHEM CO LTD NO 42 | expired | Feb 2023 |
GLICLAZIDE BP in Africa — Regulatory Overview
GLICLAZIDE BP is registered across 4 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Nigeria, Rwanda, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 2 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.